Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe

A. Lamarca; M. Morfouace; S. Tejpar; J. Oliveira; A. Capela; N. Penel; C. Gennigens; B. Brasiuniene; J. Peron; A. Stevovic; J. Y. Blay; H. J. Klümpen

doi:https://doi.org/10.1016/j.annonc.2022.07.006

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe

A. Lamarca, M. Morfouace, S. Tejpar, J. Oliveira, A. Capela, N. Penel, C. Gennigens, B. Brasiuniene, J. Peron, A. Stevovic, J. Y. Blay, H. J. Klümpen

Research output: Contribution to journal › Letter › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	1200-1202
Number of pages	3
Journal	Annals of Oncology
Volume	33
Issue number	11
DOIs	https://doi.org/10.1016/j.annonc.2022.07.006
Publication status	Published - 1 Nov 2022

Access to Document

https://doi.org/10.1016/j.annonc.2022.07.006

Cite this

Lamarca, A., Morfouace, M., Tejpar, S., Oliveira, J., Capela, A., Penel, N., Gennigens, C., Brasiuniene, B., Peron, J., Stevovic, A., Blay, J. Y., & Klümpen, H. J. (2022). Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe. Annals of Oncology, 33(11), 1200-1202. https://doi.org/10.1016/j.annonc.2022.07.006

@article{903d9159c6d94824b6ff301bf43fcae4,

title = "Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe",

author = "A. Lamarca and M. Morfouace and S. Tejpar and J. Oliveira and A. Capela and N. Penel and C. Gennigens and B. Brasiuniene and J. Peron and A. Stevovic and Blay, {J. Y.} and Kl{\"u}mpen, {H. J.}",

note = "Funding Information: This work was supported by Alliance Healthcare, a member of the AmerisourceBergen group ( EORTC SPECTA platform). F. Hoffman-La Roche Ltd. [ARCAGEN study (EORTC-1843)]. European Union{\textquoteright}s Horizon 2020 Research and Innovation Programme [grant number 825510, ESCALON] to AL .",

year = "2022",

month = nov,

day = "1",

doi = "https://doi.org/10.1016/j.annonc.2022.07.006",

language = "English",

volume = "33",

pages = "1200--1202",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "11",

}

Lamarca, A, Morfouace, M, Tejpar, S, Oliveira, J, Capela, A, Penel, N, Gennigens, C, Brasiuniene, B, Peron, J, Stevovic, A, Blay, JY & Klümpen, HJ 2022, 'Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe', Annals of Oncology, vol. 33, no. 11, pp. 1200-1202. https://doi.org/10.1016/j.annonc.2022.07.006

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe. / Lamarca, A.; Morfouace, M.; Tejpar, S. et al.
In: Annals of Oncology, Vol. 33, No. 11, 01.11.2022, p. 1200-1202.

Research output: Contribution to journal › Letter › Academic › peer-review

TY - JOUR

T1 - Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843)

T2 - too few patients with matched treatment in Europe

AU - Lamarca, A.

AU - Morfouace, M.

AU - Tejpar, S.

AU - Oliveira, J.

AU - Capela, A.

AU - Penel, N.

AU - Gennigens, C.

AU - Brasiuniene, B.

AU - Peron, J.

AU - Stevovic, A.

AU - Blay, J. Y.

AU - Klümpen, H. J.

N1 - Funding Information: This work was supported by Alliance Healthcare, a member of the AmerisourceBergen group ( EORTC SPECTA platform). F. Hoffman-La Roche Ltd. [ARCAGEN study (EORTC-1843)]. European Union’s Horizon 2020 Research and Innovation Programme [grant number 825510, ESCALON] to AL .

PY - 2022/11/1

Y1 - 2022/11/1

UR - http://www.scopus.com/inward/record.url?scp=85140374426&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.annonc.2022.07.006

DO - https://doi.org/10.1016/j.annonc.2022.07.006

M3 - Letter

C2 - 35926814

SN - 0923-7534

VL - 33

SP - 1200

EP - 1202

JO - Annals of Oncology

JF - Annals of Oncology

IS - 11

ER -

Molecular profiling and precision medicine in rare gastrointestinal cancers within EURACAN in the SPECTA Arcagen study (EORTC-1843): too few patients with matched treatment in Europe

Access to Document

Other files and links

Cite this